Rituxan (rituximab) - Roche
Infection-Related Glomerulonephritis Mimicking ANCA-Associated Vasculitis in a Patient with HIV and Multisystem Infection (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0745; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Given his persistent hemoptysis and positive ANCA titres, the patient was initiated on high-dose corticosteroids and rituximab for suspected AAV...Infection can induce both ANCA seropositivity and glomerular injury difficult to distinguish from vasculitis on biopsy, which has been described in cases of infective endocarditis. In this patient, reliance on serology and renal pathology alone could have led to further immunosuppression in an already immunocompromised patient, highlighting the importance of multi-organ evaluation in diagnostically challenging cases." 
Clinical • Acute Kidney Injury • ANCA Vasculitis • Cardiovascular • Fibrosis • Glomerulonephritis • Human Immunodeficiency Virus • Immunology • Infectious Disease • Lupus Nephritis • Nephrology • Renal Disease • Respiratory Diseases • Vasculitis • CD4
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4557089
 
Jordan Loon; Aman Pal; Kelly Beers
 
Oct 2, 2026
 
Prev Next